Synergistic antitumor effect between Olaparib and Chidamide by regulation of MYBL2 in lung cancer
{{output}}
Recently, various basic research and clinical studies have revealed the further potential of poly (adenosine diphosphate-ribose) polymerase (PARP) inhibitor Olaparib and histone deacetylase inhibitor Chidamide in lung cancer. However, no research available was... ...
